Code | 8481C | ||||||||||
MA number | 59/0238/18-S | ||||||||||
Product Form: | cps dur 21x15 mg (bli.PVC/Aclar/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | blister PVC/Aclar/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 30.07.2018 |
PIL: | PIL_Lenalidomid Zentiva 10_15_25 mg cps dur_06.2023.pdf |
SPC: | SPC_Lenalidomid Zentiva 10_15_25 mg cps dur_08.2023.pdf |
Safety feature | Yes |
Data update: | 24.04.2023 |